Laura B. Dunn
Chair and Professor
Also affiliated: American Cancer Society (2017); National Institutes of Health (2024); Mayo Clinic (2011); Memorial Sloan Kettering Cancer Center (2013); Kaiser Permanente (2011); University of California, Los Angeles (2018); Flinders University (2025); University of Pittsburgh (2017–2024); University of California, San Francisco (2007–2024); SUNY Upstate Medical University (2021); Medical College of Wisconsin (2008–2009); VA Palo Alto Health Care System (2017); University of South Florida (2013); Brown University (2024); University of Arkansas Medical Center (2025); East London NHS Foundation Trust (2024); Langley Porter Psychiatric Hospital and Clinics (2014); University of California System (2014); University of California San Diego (2001–2025); VA San Diego Healthcare System (2002–2008); San Diego Hospice and The Institute for Palliative Medicine (2012); University of California San Francisco Medical Center (2014); Dana-Farber Cancer Institute (2022); Kaiser Permanente San Francisco Medical Center (2011); University of Pittsburgh Medical Center (2021); Stanford Medicine (2007–2022); Eunice Kennedy Shriver National Institute of Child Health and Human Development (2024); Alta Bates Summit Medical Center (2011); UCSF Helen Diller Family Comprehensive Cancer Center (2011–2015); UCL Queen Square Institute of Neurology (2010–2013); University College London (2008–2013); Imperial College London (2014); University of Greenwich (2000); New York University (2016); Columbia University (2007–2008); Stanford University (2007–2022); Icahn School of Medicine at Mount Sinai (2024)
Psychiatry, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Laura B. Dunn's research focuses on behavioral and psychological studies, particularly concerning health sciences research and education. She has investigated medication adherence in patients with schizophrenia, comparing adherence rates between typical and atypical antipsychotic agents. Dunn has also developed and reviewed instruments for assessing decisional capacity, a crucial aspect of informed consent for clinical research and treatment. Her work has extended to understanding medical student well-being, exploring factors that promote resilience and prevent burnout.
Dunn's scholarship is reflected in a substantial publication record, with 309 total publications and over 13,000 citations, contributing to her h-index of 59. She is recognized as a highly cited researcher. Her collaborations within the University of Arkansas for Medical Sciences include work with G. Andrew James, Tatiana Wolfe, Clint Kilts, and Srinivasa Gokarakonda.
Her recent research includes examining dysregulation of glucose metabolism in sporadic Parkinson's disease and reviewing internet interventions for improving psychological well-being in psycho-oncology. Dunn maintains an active lab website and leads a research group, indicating ongoing research activities.
Metrics
- h-index: 60
- Publications: 307
- Citations: 13,233
Positions
-
Chair and Professor 2022–presentUniversity of Arkansas for Medical Sciences Psychiatry, College of Medicine Institutional directory
-
Professor of Psychiatry & Behavioral Sciences 2015–2022Stanford University Psychiatry & Behavioral Sciences ORCID
Selected Publications
-
Associations of personality profiles with stress and resilience characteristics among patients undergoing cancer chemotherapy (2026)
-
How to Network and Be a Good Colleague (2025)
-
How to Write Socially (2025)
-
484 A Preliminary Study on the Pharmacodynamics of Oral Cannabis Ingestion in Older Adults (2024)
-
Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients (2024)
-
Becoming an Authentic, Resilient Leader: An Interactive Workshop to Enhance Your Abilities to Lead (2024)
-
Academic machine learning researchers’ ethical perspectives on algorithm development for health care: a qualitative study (2023)
-
Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study (2023)
-
Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster (2023)
-
Is it worth it? Greater risk aversion with lower life satisfaction among depressed individuals (2023)
-
Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders (2023)
-
Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues (2023)
-
Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers (2023)
-
Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy (2022)
-
Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer (2022)
Collaboration Network
Top Collaborators
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
Showing 5 of 6 shared publications
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
Showing 5 of 6 shared publications
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Depression trajectories among women undergoing chemotherapy.
- Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Depression trajectories among women undergoing chemotherapy.
- Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
Similar Researchers
Based on overlapping research topics